부산대학교 도서관

Overman, RG; Enderle, PJ; Farrow, JM; Wiley, JE; Farwell, MA

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION; AUG 25 2003, 1628 3, p195-p205, 11p.

Overman, RG; Farwell, MA

FASEB JOURNAL; APR 23 1999, 13 7, pA1554-pA1554, 1p. Supplement: S

Sawant S; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Gurley SA; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Overman RG; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Sharak A; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Mudrak SV; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Oguin T 3rd; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Sempowski GD; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Sarzotti-Kelsoe M; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Walter EB; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Pediatrics, Duke University, Durham, NC, United States.; Duke Global Health Institute, Duke University, Durham, NC, United States.; Xie H; Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.; Pasetti MF; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, United States.; Moody MA; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Department of Pediatrics, Duke University, Durham, NC, United States.; Tomaras GD; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Duke Global Health Institute, Duke University, Durham, NC, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Ricupero S; The Pennsylvania State University, United States.; Carpenter CM; The Pennsylvania State University, United States.; Steinkrauss AC; The Pennsylvania State University, United States.; Gerver CR; The Pennsylvania State University, United States.; Chamberlain JD; The Pennsylvania State University, United States.; Monkman RG; Elon University, United States.; Overman AA; Elon University, United States.; Dennis NA; The Pennsylvania State University, United States. Electronic address: nad12@psu.edu.

Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 0045503 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6240 (Electronic) Linking ISSN: 00068993 NLM ISO Abbreviation: Brain Res Subsets: MEDLINE

Tay MZ; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.; Kunz EL; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Deal A; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Zhang L; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Seaton KE; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Rountree W; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Eudailey JA; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Heptinstall J; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; McRaven MD; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Matias E; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; McGuire E; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Yates NL; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Perez LG; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Department of Surgery, Duke University, Durham, North Carolina, USA.; Montefiori DC; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Department of Surgery, Duke University, Durham, North Carolina, USA.; Overman RG; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Hope TJ; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Shen X; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Kalilani L; College of Medicine, University of Malawi, Blantyre, Malawi.; Fouda GG; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.; Department of Pediatrics, Duke University, Durham, North Carolina, USA.; Tomaras GD; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA gdt@duke.edu sallie.permar@dm.duke.edu.; Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.; Department of Surgery, Duke University, Durham, North Carolina, USA.; Department of Immunology, Duke University, Durham, North Carolina, USA.; Permar SR; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA gdt@duke.edu sallie.permar@dm.duke.edu.; Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.; Department of Pediatrics, Duke University, Durham, North Carolina, USA.

Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE

Bradley T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: todd.bradley@duke.edu.; Peppa D; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK.; Pedroza-Pacheco I; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK.; Li D; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Cain DW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.; Henao R; Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC 27710, USA.; Venkat V; Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC 27710, USA.; Hora B; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Chen Y; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Vandergrift NA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.; Overman RG; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Edwards RW; Department of Surgery, Duke University, Durham, NC 27710, USA.; Woods CW; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC 27710, USA.; Tomaras GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.; Ferrari G; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.; Ginsburg GS; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC 27710, USA.; Connors M; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.; Cohen MS; University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Moody MA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.; Borrow P; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK. Electronic address: persephone.borrow@ndm.ox.ac.uk.; Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Saunders KO; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kevin.saunders@dm.duke.edu.; Nicely NI; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Wiehe K; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Bonsignori M; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Meyerhoff RR; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Parks R; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Walkowicz WE; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA.; Aussedat B; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA.; Wu NR; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Cai F; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Vohra Y; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA.; Park PK; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA.; Eaton A; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Go EP; University of Kansas, Lawrence, KS 66045, USA.; Sutherland LL; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Scearce RM; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.; Zhang R; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Von Holle T; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Overman RG; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Anasti K; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Sanders RW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.; Moody MA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Kepler TB; Boston University, Boston, MA 02215, USA.; Korber B; LANL, Los Alamos, NM 87545, USA.; Desaire H; University of Kansas, Lawrence, KS 66045, USA.; Santra S; Harvard Medical School, Boston, MA, 02215, USA.; Letvin NL; Harvard Medical School, Boston, MA, 02215, USA.; Nabel GJ; Sanofi, Cambridge, MA 02139, USA.; Montefiori DC; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.; Tomaras GD; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Liao HX; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Alam SM; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Danishefsky SJ; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA.; Haynes BF; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Martins LF; Centre for Parasitology and Mycology, Instituto Adolfo Lutz , Avenida Dr. Arnaldo, 351, 8° andar, 01246-000 São Paulo, SP, Brazil.; Mesquita JT; Centre for Parasitology and Mycology, Instituto Adolfo Lutz , Avenida Dr. Arnaldo, 351, 8° andar, 01246-000 São Paulo, SP, Brazil.; Pinto EG; Centre for Parasitology and Mycology, Instituto Adolfo Lutz , Avenida Dr. Arnaldo, 351, 8° andar, 01246-000 São Paulo, SP, Brazil.; Instituto de Medicina Tropical, Universidade de São Paulo , Avenida Dr. Enéas de Carvalho Aguiar, 470, 05403-000 São Paulo, SP, Brazil.; Costa-Silva TA; Centre for Parasitology and Mycology, Instituto Adolfo Lutz , Avenida Dr. Arnaldo, 351, 8° andar, 01246-000 São Paulo, SP, Brazil.; Borborema SE; Centre for Parasitology and Mycology, Instituto Adolfo Lutz , Avenida Dr. Arnaldo, 351, 8° andar, 01246-000 São Paulo, SP, Brazil.; Galisteo Junior AJ; Instituto de Medicina Tropical, Universidade de São Paulo , Avenida Dr. Enéas de Carvalho Aguiar, 470, 05403-000 São Paulo, SP, Brazil.; Neves BJ; LabMol, Laboratory for Molecular Modeling and Drug Design, Faculdade de Farmácia, Universidade Federal de Goiás , Goiânia, Brazil.; Andrade CH; LabMol, Laboratory for Molecular Modeling and Drug Design, Faculdade de Farmácia, Universidade Federal de Goiás , Goiânia, Brazil.; Shuhaib ZA; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Bennett EL; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Black GP; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Harper PM; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Evans DM; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Fituri HS; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Leyland JP; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Martin C; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Roberts TD; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Thornhill AJ; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Vale SA; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Howard-Jones A; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Thomas DA; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Williams HL; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Overman LE; University of California, Irvine , 4042A Frederick Reines Hall, Irvine, California 92697, United States.; Berlinck RG; Instituto de Química de São Carlos, Universidade de São Paulo , CP 780, CEP 13560-970, São Carlos, SP, Brazil.; Murphy PJ; School of Chemistry, Bangor University , Bangor, Gwynedd, Wales, U.K. LL57 2UW.; Tempone AG; Centre for Parasitology and Mycology, Instituto Adolfo Lutz , Avenida Dr. Arnaldo, 351, 8° andar, 01246-000 São Paulo, SP, Brazil.

Publisher: American Society of Pharmacognosy Country of Publication: United States NLM ID: 7906882 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6025 (Electronic) Linking ISSN: 01633864 NLM ISO Abbreviation: J Nat Prod Subsets: MEDLINE

Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. fjanku@mdanderson.org.; Huang HJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Claes B; Biocartis, Mechelen, Belgium.; Falchook GS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. Sarah Cannon Research Institute at HealthONE, Denver, Colorado.; Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hong D; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ramzanali NM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Nitti G; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cabrilo G; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wheler JJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Karp DD; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Holley VR; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Zinner RG; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Luthra R; Molecular Diagnostic Laboratory, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kee BK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Devogelaere B; Biocartis, Mechelen, Belgium. Cartagenia, Leuven, Belgium.; Sablon E; Biocartis, Mechelen, Belgium.; Maertens G; Biocartis, Mechelen, Belgium.; Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kurzrock R; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. Moores Cancer Center, The University of California San Diego, La Jolla, California.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

Pollara J; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.; McGuire E; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Fouda GG; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Rountree W; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Eudailey J; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Overman RG; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Seaton KE; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Deal A; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Edwards RW; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.; Tegha G; The University of North Carolina Project, Lilongwe, Malawi.; Kamwendo D; The University of North Carolina Project, Lilongwe, Malawi.; Kumwenda J; The University of North Carolina Project, Lilongwe, Malawi.; Nelson JA; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Liao HX; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Brinkley C; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Denny TN; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Ochsenbauer C; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Ellington S; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; King CC; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Jamieson DJ; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; van der Horst C; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Kourtis AP; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Tomaras GD; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Ferrari G; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.; Permar SR; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA sallie.permar@dm.duke.edu.

Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE